In addition, inhibition of miR-19 and miR-155 reactivated the expression of SOCS1 and p53 in mouse leukemia and human myeloma cells, leading to subsequent inhibition of cell proliferation, cell migration, and tumor progression [154]. This evidence concerns the gene SOCS1 and leukemia.